Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion

Thread starter U.S. News
Start date Apr 21, 2026

U.S. News

Guest

Apr 21, 2026

Kelonia is developing technology to reprogram patients' T-cells inside the body so those cells can attack cancer, called in vivo CAR-T.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: Eli Lilly agrees to acquire cancer drug maker Kelonia in deal worth up to $7 billion

Prefix: N/A

Forum: USA News

Start date: Apr 21, 2026

Last reply date: Apr 21, 2026

Replies: 0

Thread Tags

Thread statistics

Created: U.S. News, Apr 21, 2026

Replies: 0

Views: 2

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search